The clinical guidelines, protocols, policies and other materials made available through the Website are provided for informational, clinical governance, operational and professional healthcare purposes.
Users may download, print, reproduce and share such materials for legitimate healthcare, business, compliance, educational or regulatory purposes, including with:
Unless otherwise stated, all clinical guidelines, protocols, content and materials published on the Website remain the property of NAS and/or its licensors and are protected by applicable intellectual property laws. Publication of such materials on the Website does not transfer any ownership or intellectual property rights to users.
Users shall not modify, alter, misrepresent or create derivative versions of any material in a manner that is misleading or removes any copyright, attribution, disclaimer or version-control information contained within the document.
The clinical guidelines and related materials are provided for guidance purposes only and do not constitute medical advice, diagnosis, treatment recommendations, legal advice or regulatory advice.
Healthcare providers and healthcare professionals remain solely responsible for exercising their own independent clinical judgment and ensuring compliance with all applicable laws, regulations, licensing requirements and professional standards, including the requirements of the relevant health authorities and regulators.
NAS reserves the right to amend, update, replace or withdraw any clinical guideline or related material at any time without prior notice. Users are responsible for ensuring that they are relying on the most current version available.
To the fullest extent permitted by applicable law, NAS shall not be liable for any loss, damage, claim, liability, regulatory action or consequence arising from or relating to the use of, reliance upon, reproduction, distribution or implementation of any clinical guideline or material made available through the Website.
Reach the NAS Neuron legal team directly and we'll get back to you within two business days.